OBJECTIVE: Conflicting data exists regarding the frequency and significance of acute kidney injury (AKI) in ST segment elevation MI (STEMI) patients. The acute kidney injury network (AKIN) classification has been shown to predict mortality in various critically ill patients; however, limited information is available regarding its use and its clinical relevance among STEMI patients. STUDY DESIGN AND METHODS: We retrospectively studied 1,033 STEMI patients undergoing primary percutaneous intervention (PCI). AKI was identified on the basis of the changes in serum creatinine during hospitalization according to the AKIN criteria. Patients were assessed for in-hospital adverse outcomes as well as all-cause mortality up to 5 years. RESULTS: Overall, 100 patients (9.6 %) developed AKI: 79 patients (79 %) had stage 1, 14 patients (14 %) developed stage 2, and 7 patients (7 %) developed stage 3 AKI. Patients with AKI had more complications during hospitalization, with higher 30 days (11 vs 1 %; p < 0.001) and 5-year all-cause mortality (29 vs 6 %; p < 0.001) compared to those without AKI. The adjusted risk of death increased proportionally to AKI severity. Compared to patients with no AKI, the adjusted hazard ratio for all-cause mortality was 6.68 (95 % confidence interval: 2.1-21.6, p = 0.002) in patients with AKI. Age, hypertension, chronic kidney injury and low left ventricular ejection fraction were independent predictors of developing AKI. CONCLUSION: In STEMI patients undergoing primary PCI, AKI assessed by AKIN criteria is a frequent complication, associated with an increased risk of both short- and long-term mortality.
OBJECTIVE: Conflicting data exists regarding the frequency and significance of acute kidney injury (AKI) in ST segment elevation MI (STEMI) patients. The acute kidney injury network (AKIN) classification has been shown to predict mortality in various critically illpatients; however, limited information is available regarding its use and its clinical relevance among STEMI patients. STUDY DESIGN AND METHODS: We retrospectively studied 1,033 STEMI patients undergoing primary percutaneous intervention (PCI). AKI was identified on the basis of the changes in serum creatinine during hospitalization according to the AKIN criteria. Patients were assessed for in-hospital adverse outcomes as well as all-cause mortality up to 5 years. RESULTS: Overall, 100 patients (9.6 %) developed AKI: 79 patients (79 %) had stage 1, 14 patients (14 %) developed stage 2, and 7 patients (7 %) developed stage 3 AKI. Patients with AKI had more complications during hospitalization, with higher 30 days (11 vs 1 %; p < 0.001) and 5-year all-cause mortality (29 vs 6 %; p < 0.001) compared to those without AKI. The adjusted risk of death increased proportionally to AKI severity. Compared to patients with no AKI, the adjusted hazard ratio for all-cause mortality was 6.68 (95 % confidence interval: 2.1-21.6, p = 0.002) in patients with AKI. Age, hypertension, chronic kidney injury and low left ventricular ejection fraction were independent predictors of developing AKI. CONCLUSION: In STEMI patients undergoing primary PCI, AKI assessed by AKIN criteria is a frequent complication, associated with an increased risk of both short- and long-term mortality.
Authors: Seung Hwan Hwang; Myung Ho Jeong; Khurshid Ahmed; Min Chul Kim; Kyung Hoon Cho; Min Goo Lee; Jum Suk Ko; Keun Ho Park; Doo Sun Sim; Nam Sik Yoon; Hyun Ju Yoon; Kye Hun Kim; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Young Keun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang Journal: Int J Cardiol Date: 2011-04-08 Impact factor: 4.164
Authors: Hans Erik Bøtker; Rajesh Kharbanda; Michael R Schmidt; Morten Bøttcher; Anne K Kaltoft; Christian J Terkelsen; Kim Munk; Niels H Andersen; Troels M Hansen; Sven Trautner; Jens Flensted Lassen; Evald Høj Christiansen; Lars R Krusell; Steen D Kristensen; Leif Thuesen; Søren S Nielsen; Michael Rehling; Henrik Toft Sørensen; Andrew N Redington; Torsten T Nielsen Journal: Lancet Date: 2010-02-27 Impact factor: 79.321
Authors: Maria Koreny; Georg Delle Karth; Alexander Geppert; Thomas Neunteufl; Ute Priglinger; Gottfried Heinz; Peter Siostrzonek Journal: Am J Med Date: 2002-02-01 Impact factor: 4.965
Authors: Matthew T James; Susan M Samuel; Megan A Manning; Marcello Tonelli; William A Ghali; Peter Faris; Merril L Knudtson; Neesh Pannu; Brenda R Hemmelgarn Journal: Circ Cardiovasc Interv Date: 2013-01-15 Impact factor: 6.546
Authors: Giancarlo Marenzi; Emilio Assanelli; Jeness Campodonico; Gianfranco Lauri; Ivana Marana; Monica De Metrio; Marco Moltrasio; Marco Grazi; Mara Rubino; Fabrizio Veglia; Franco Fabbiocchi; Antonio L Bartorelli Journal: Ann Intern Med Date: 2009-02-03 Impact factor: 25.391
Authors: L K Newby; W R Rutsch; R M Califf; M L Simoons; P E Aylward; P W Armstrong; L H Woodlief; K L Lee; E J Topol; F Van de Werf Journal: J Am Coll Cardiol Date: 1996-06 Impact factor: 24.094